12/19/2013

GlaxoSmithKline has launched a $1 million innovation contest in the area of bioelectronic technology. The challenge calls on scientists to develop a miniaturized, fully implantable device that can be used to treat medical conditions by reading, writing and interfering with the body's electrical signals.

Full Story:
MedCityNews.com

Related Summaries